Immune Contribution to Heart Failure and Therapeutic Opportunities
Event Date: October 27, 2020
Deadline to Submit Abstracts: September 30, 2020
Despite recent advances in treatment options, and trending improvements in survival over the last several decades, therapeutic interventions for heart failure largely fail to resolve the underlying disease. Understanding the pathophysiological role of inflammatory cells in response to myocardial damage presents a new area of therapeutic opportunity. This symposium will focus on novel immunological mechanisms that contribute to the onset and progression of heart failure, and discussions will include the post-myocardial infarct immune system, hypertension-induced cardiac inflammation, macrophages and their role in ischemic and non-ischemic heart failure, and the anti-inflammatory hypothesis. A special focus will be given to the current state of small molecule and biologic therapies targeting the immune system for this disease.
To register for this event, please visit the main website at: www.nyas.org/Immunocardiology